- Osteoporosis Drug May Benefit Heart Health
The osteoporosis drug alendronate was linked with a reduced risk of cardiovascular death, heart attack, and stroke in a study of patients with hip fractures. - Targeting Cellular Senescence Could Halt Age-Related Bone Loss
Inhibiting cellular senescence could be a novel therapeutic strategy to prevent bone loss and other age-related diseases, according to a mini-review recently published... - Researchers Compare Health Status, Rates of Cardiometabolic Disease Between Transgender Adults and Cisgender Adults
- ESAP 2018: Diagnosing Tumor-induced Osteomalacia
- Remembering Neena B. Schwartz, PhD: A Lab & Life of Her Making
Early Registration is now open for Endocrine Board Review 2018 taking place September 4–5 in Miami, Florida.
Clinical Endocrinology Update (CEU) will provide you with the opportunity to learn from and network with faculty at the forefront of endocrine practice and research. Early Registration is now open for:
For endocrinologists determined to go beyond certification and provide the best in patient care, the Endocrine Self-Assessment Program (ESAP™) delivers. ESAP 2018 covers a wide range of topics in endocrinology, diabetes, and metabolism in an online format with a complementary printed book.
Accelerating Scientific Breakthroughs. Curing and Caring for Patients. Improving Health Worldwide.
Glucocorticoid-Induced Metabolic Disturbances Are Exacerbated in Obese Male Mice
We evaluated lipolytic markers, insulin resistance, and hepatic steatosis in response to combined glucocorticoids and obesity in mice. All outcomes were exacerbated in comparison to lean counterparts.
We report a negative association between INSL3 and sclerostin in vivo and in vitro, suggesting new pathways in the emerging role of testis in the regulation of bone metabolism.
Evaluating Causality of Gut Microbiota in Obesity and Diabetes in Humans
We have reviewed the evidence of the gut microbiome as a driving force in the development of obesity and type 2 diabetes mellitus. Considering overlap in potential mechanisms, the role of the gut microbiome in type 1 diabetes mellitus will also be addressed.
Sex Difference In the Effect of Fetal Exposure to Maternal Diabetes on Insulin Secretion
Insulin secretion was evaluated in adults who have been exposed in utero to maternal T1D. Only women (not men) exhibited decreased insulin secretion in response to intravenous glucose.